|
Volumn 113, Issue 10, 2008, Pages 2627-2637
|
Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007
a b c d,s e,u f g,r h i,w j k l m n o p q t v x more.. |
Author keywords
BRCA mutations; Breast cancer; International conference; Patient management guidelines; Risk factors
|
Indexed keywords
BRCA1 PROTEIN;
BRCA2 PROTEIN;
ORAL CONTRACEPTIVE AGENT;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
TAMOXIFEN;
BREAST CANCER;
CANCER RISK;
CANCER STAGING;
CONFERENCE PAPER;
CONSENSUS;
FOLLOW UP;
GENE MUTATION;
GENETIC SCREENING;
HEALTH CARE ORGANIZATION;
HORMONE SUBSTITUTION;
HUMAN;
MAMMOGRAPHY;
MASTECTOMY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ONCOGENE;
OVARIECTOMY;
OVARY CANCER;
PATIENT CARE;
PATIENT COUNSELING;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
PROPHYLAXIS;
QUALITY OF LIFE;
RISK ASSESSMENT;
RISK FACTOR;
RISK MANAGEMENT;
RISK REDUCTION;
SENTINEL LYMPH NODE BIOPSY;
BREAST NEOPLASMS;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MUTATION;
PREVALENCE;
RISK FACTORS;
RISK MANAGEMENT;
|
EID: 55849093873
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/cncr.23903 Document Type: Conference Paper |
Times cited : (85)
|
References (0)
|